Trial Profile
A phase I trial to evaluate repetitive intravenous doses of gadolinium texaphyrin [motexafin gadolinium] as a radiosensitizer in patients with glioblastoma multiforme
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Jul 2018
Price :
$35
*
At a glance
- Drugs Motexafin gadolinium (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Pharmacokinetics
- 02 Oct 2005 New trial record.